UriPath™ & UriPath-STI™

UriPath™ & UriPath-STI™

Urinary Tract Infections (UTI) are often serious in elderly adults. Fever and pain during urination forces patients to seek medical attention. Severe cases of UTI can lead to wounds in the urethra and possible kidney damage. The Candida infection, the bacterial infections from Escherichia coli and Klebsiella pneumoniae are the most frequently detected pathogens. Several species of Proteus are also frequently present in catheterized patients. Additionally, Morganella morganii is often associated with kidney stone formation.

NCF Diagnostics & DNA Technologies developed our UriPath™ Real-Time PCR assay (UriPath™) which can provide detailed information about the pathogens present in patients’ urine and their corresponding quantities.

Sexually Transmitted Infections (STI) are serious among adults and may cause chlamydia, gonorrhea, vaginosis, infertility, or uterine cancer, depending on the specific pathogen causing the STI. According to the CDC, 1.7 million chlamydia and 0.5 million gonorrhea infections occurred in 2017. Sexually Transmitted Infections remain as a hidden epidemic in the United States.

NCF Diagnostics & DNA Technologies created the UriPath-STI™ test which screens for different STI pathogens potentially present in patient urine specimens. UriPath-STI™ provides a precise, targeted identification of any such pathogens identified.

NCF Diagnostics & DNA Technologies has extensive experience utilizing Real-Time PCR for testing patients’ urine specimens. Testing over 100,000 patients’ urine since 2017, specimens received from urologists, gynecologists, eldercare facilities and primary care practices are tested and resulted daily.

UriPath™ & UriPath-STI™ testing kits can be ordered from NCF Diagnostics & DNA Technologies.

Download 2021 NCF_UriPath_Requisition_Form
Download 2021 NCF_UriPath_UriStiPath_Requisition_Form